This trial looks at whether the MyoPro device can help improve upper extremity function in people with incomplete spinal cord injury.
6 Primary · 0 Secondary · Reporting Duration: Approximately 10 weeks
Active Control
Experimental Treatment
24 Total Participants · 3 Treatment Groups
Primary Treatment: MyoMo · No Placebo Group · N/A
Age 18 - 80 · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:New York | 100.0% |
< 18 | 100.0% |
Kessler Foundation | 100.0% |
Met criteria | 100.0% |